Expert consensus on the monitoring of transthyretin amyloid cardiomyopathyPablo García‐Pavía, Perry Elliott, Frank M. Bengel et al.|European Journal of Heart Failure|2021Cited by 173
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Journal of Cardiovascular Pharmacology|2020Cited by 111
Organization of Heart Failure Management in European Society of Cardiology Member Countries: Survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working GroupsPetar Seferović, Stefan D. Anker, Gerasimos Filippatos et al.|European Journal of Heart Failure|2013Cited by 83
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Cardiac failure review|2020Cited by 67
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025Vijay Chopra, Tzung‐Dau Wang, William T. Abraham et al.|Heart Lung and Circulation|2025Cited by 10